Solania Rios
Medical · Perth Amboy, NJNPI 1376774307
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 532 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 14.6% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 532 payments — averaging $16.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Bayer$1K
- GSK$810
- AbbVie$753
- Novo Nordisk$729
- Boehringer Ingelheim$629
- plus $4K from 29 others
What the payments were for
- Food & beverage$8,917100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 53 | $1,303 |
| Bayer | 55 | $1,027 |
| GSK | 47 | $810 |
| AbbVie | 47 | $753 |
| Novo Nordisk | 52 | $729 |
| Boehringer Ingelheim | 41 | $629 |
| Amgen | 41 | $580 |
| Lilly USA, LLC | 22 | $345 |
| Novartis | 20 | $338 |
| Exact Sciences | 13 | $281 |
| Amarin Pharma, Inc. | 16 | $223 |
| Corcept Therapeutics | 15 | $203 |
| Eisai Inc. | 12 | $199 |
| Cvrx, Inc. | 13 | $191 |
| Ironwood Pharmaceuticals, Inc | 10 | $191 |
| Sanofi-aventis U.S. LLC | 14 | $188 |
| Pfizer | 10 | $150 |
| Lundbeck LLC | 8 | $131 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $86 |
| Abbott | 4 | $73 |
| Biogen | 5 | $71 |
| Merck | 4 | $56 |
| Otsuka America Pharmaceutical, Inc. | 3 | $56 |
| Ardelyx, Inc. | 3 | $51 |
| Mylan Specialty L.p. | 3 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $43 |
| Azurity Pharmaceuticals, Inc. | 2 | $30 |
| Johnson & Johnson | 2 | $27 |
| Nestle Healthcare Nutrition Inc. | 2 | $26 |
| Pulmonx Corporation | 1 | $24 |
| Radius Health, Inc. | 1 | $16 |
| Optinose US, Inc. | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,931 in reported general payments places this provider in the 95th percentile of 573 medical providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 271 | $237,418 |
| TradjentaLinagliptin | 252 | $209,601 |
| JardianceEmpagliflozin | 188 | $197,934 |
| OzempicSemaglutide | 165 | $163,109 |
| JanuviaSitagliptin Phosphate | 176 | $135,776 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 150 | $103,973 |
| LinzessLinaclotide | 128 | $100,256 |
| MounjaroTirzepatide | 91 | $99,571 |
| Enbrel SureclickEtanercept | 14 | $97,701 |
| EliquisApixaban | 121 | $88,999 |
| JanumetSitagliptin Phos/Metformin Hcl | 75 | $70,071 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 104 | $64,921 |
| TrulicityDulaglutide | 44 | $54,308 |
| ProliaDenosumab | 31 | $50,831 |
| RybelsusSemaglutide | 36 | $46,282 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimTradjenta, Jardiance, Synjardy Xr | $629 | $435,942471 claims |
| MerckJanuvia, Janumet, Janumet Xr | $56 | $270,767355 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Brilinta | $1,303 | $263,223316 claims |
| Novo NordiskOzempic, Rybelsus | $729 | $209,391201 claims |
| Lilly USA, LLCMounjaro, Trulicity | $345 | $153,879135 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $810 | $144,590249 claims |
| AbbVieLinzess | $753 | $100,256128 claims |
| PfizerEliquis | $150 | $88,999121 claims |
| AmgenProlia | $580 | $50,83131 claims |
| BayerKerendia | $1,027 | $19,26324 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $188 | $10,83613 claims |
| NovartisEntresto | $338 | $9,91516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 573 medical providers in New Jersey.
Other medical in Perth Amboy
- Shannon WelnerVerona$176K
- Christinna DelgenioColts Neck$114K
- Anita FoxVerona$17K
- Therese CasasKinnelon$16K
- Joseph CollettiLinwood$16K
- Melissa MiaoKearny$14K
- Gabriela Plesek-AndiaVerona$13K
- Stephanie PhillipsMarlton$12K
- Sean AdairCape May Court House$12K
- Shane CourtneyLinwood$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.